治疗肥胖的草药治疗方法:一篇评论
Amin Gasmi1, Sadaf Noor2, Pavan Kumar Mujawdiya3
1Department of Research, Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Current medicinal chemistry
|March 21, 2024
概括
草本植物为肥胖治疗提供了安全有效的替代方案,其活性化合物针对减肥和代谢健康. 研究强调它们的抗肥胖,抗糖尿病和抗炎功效.
科学领域:
- 代谢障碍和草药治疗方法
- 自然产品化学 自然产品化学
背景情况:
- 肥胖是一种广泛的代谢障碍,与糖尿病,高血压和心血管疾病有关.
- 目前的肥胖治疗方法,包括药物和手术,都有局限性和不良影响.
- 药物干预肥胖症往往是昂贵的,推动了寻找替代品的搜索.
研究的目的:
- 审查各种草药在肥胖管理中的治疗潜力.
- 为了确定这些草药中对抗肥胖作用负责的关键二次代谢物.
- 探索这些天然化合物的抗糖尿病和抗炎性质.
主要方法:
- 关于草本植物及其抗肥胖作用的科学研究的文献综述.
- 从选定的草药中识别代谢活性二次代谢物.
- 在体外和体内生物实验数据和临床试验的分析.
主要成果:
- 一些草药,包括Berberis vulgaris L,Rhizoma Coptidis和,表现出显著的抗肥胖特性.
- 这些草药中的活性化合物在减少累积的身体脂肪方面表现出有效性.
- 这些草药还具有显著的抗糖尿病和抗炎作用.
结论:
- 草药是一种安全,有效和经济高效的方法来控制肥胖.
- 来自植物的天然化合物为代谢障碍提供了新的治疗策略.
- 建议对这些自然资源进行进一步的研究和利用,以开发新的治疗方法.
相关概念视频
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients
368
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


